Navigation Links
Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results
Date:4/14/2009

ingredients, to be commercialized as a dietary supplement and a new functional food product line by Weider Global Nutrition.

Neptune Krill Oil, NKO(R), enters WALGREENS

Schiff Nutrition International Inc. has launched Schiff(R) MegaRed(TM) containing Neptune Krill Oil (NKO(R)) in Walgreens, which represents the largest retail pharmacy chain in the United States with over 6,400 drug stores nationwide.

Neptune completes up to $8.5 million debt financing with Desjardins Group

The Company expects the funds to be used to improve productivity and increase production capacity.

Formation of an operating pharmaceutical subsidiary named Acasti Pharma

Neptune structured part of its pharmaceutical operations into its subsidiary Acasti Pharma to carry out the research, development and commercialization of active pharmaceutical ingredients for chronic cardiovascular disease and to partner with pharmaceutical companies.

OmegaGen(R) marketed in Australia

OmegaGen(R) Neptune Krill Oil NKO(R), a complementary medicine, has been made widely available in Australia at the majority of pharmacy chains nationwide.

Breakthrough of Schiff(R) MegaRed(TM) in Costco USA

Schiff(R) MegaRed(TM) containing Neptune Krill Oil, NKO(R), has been listed as a permanent item in Costco in the United States.

Please visit us at our newly designed website at www.neptunebiotech.com.

About Neptune Technologies & Bioressources Inc.

Neptune is the pioneer and leader in marine omega-3 phospholipids, which are the highest quality Omega-3s available in the market, clinically shown to be effective in cholesterol management, joint health, inflammation and cognitive function. Neptune Krill Oil NKO(R) represents the first and only, clinicall
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
2. Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update
3. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
4. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
5. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
6. Neptune Technologies receives GRAS notification in the United States
7. Neptune Technologies expands into medicinal markets in Asia Pacific
8. Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications
9. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
10. Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones
11. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Nano Technology Products (ACAMP) hosts, ... /PRNewswire/ - Today ACAMP hosted a health & ... and microfluidics can play a powerful role in ... promote health and improve the quality, cost and ...
(Date:12/4/2009)... (OTC Bulletin Board: BFRE), a company focused on changing the ... non-food cellulosic wastes, has been ranked number 19 on the ... in Bioenergy;" the company,s second consecutive year in the top ... top 20 bioenergy companies for two straight years is a ...
(Date:12/3/2009)... 3 Nikon Corporation, an innovator of advanced ... a licensing agreement with Harvard University granting Nikon ... Microscopy (STORM) technology. Under the terms of the ... and market them with the N-STORM name. ...
(Date:12/3/2009)... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... the treatment of cardiovascular and metabolic disease, today announced ... its Phase 2 FDG-PET clinical trial of VIA-2291. ... carried out at five sites in the US and ...
Breaking Biology Technology:Alberta companies delivering new products to the health & medical marketplace 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4
... May 7 Champions,Biotechnology, Inc. (OTC Bulletin ... of advanced preclinical platforms and tumor specific ... today announced that it has,established an agreement ... of certain therapeutic antibodies in ImClone,s,clinical development ...
... 7 NeurogesX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical ... today announced it will,report results for its first quarter ... A conference call to review the results will ... 15, 2008 and will be hosted by Anthony DiTonno,President ...
... Biotech Ltd. (Amex: SVA ),a leading provider of ... and Ms. Helen Yang, International Business Manager, are scheduled,to ... All-China Conference,on Monday, May 19, 2008 at 10:15 a.m. ... NY., Ms. Nan Wang, Vice President, and Ms. ...
Other Biology Technology:Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs 2Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs 3NeurogesX to Report First Quarter 2008 Financial Results 2NeurogesX to Report First Quarter 2008 Financial Results 3Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008 2
(Date:12/4/2009)... used by physicians and scientists to study brain function ... largely unknown whether the electrodes on the head give ... brain. Scientists at the Max Planck Institute for Biological ... link between the activity generated within the brain to ...
(Date:12/4/2009)... amyloids the fibrous protein deposits associated with diseases such ... potential new area for therapeutics. , It was believed that ... known as fibres - are inert, but that there may ... and cause disease. , But in a paper published ...
(Date:12/3/2009)... and adapt to changes in our daily environment, as well ... minute junctions where nerve cells communicate, according to a new ... published online this week in the journal Nature . ... professor of physiology and neuroscience at NYU School of Medicine, ...
Breaking Biology News(10 mins):How to read brain activity? 2New therapy targets for amyloid disease 2Lifelong memories linked to stable nerve connections 2Solta Medical Reports Strong Second Quarter 2009 Results 53291 1Solta Medical Reports Strong Second Quarter 2009 Results 53291 2Solta Medical Reports Strong Second Quarter 2009 Results 53291 3Solta Medical Reports Strong Second Quarter 2009 Results 53291 4Solta Medical Reports Strong Second Quarter 2009 Results 53291 5Solta Medical Reports Strong Second Quarter 2009 Results 53291 6Solta Medical Reports Strong Second Quarter 2009 Results 53291 7Solta Medical Reports Strong Second Quarter 2009 Results 53291 8Solta Medical Reports Strong Second Quarter 2009 Results 53291 9Solta Medical Reports Strong Second Quarter 2009 Results 53291 10Solta Medical Reports Strong Second Quarter 2009 Results 53291 11Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 1Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 2Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 3Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 4Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 5Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 6Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 7Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 8Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 9Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 10Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 53289 11Nephros Inc Completes 241 25 Million Private Placement 53287 1Nephros Inc Completes 241 25 Million Private Placement 53287 2Nephros Inc Completes 241 25 Million Private Placement 53287 3
... University of Utah biologists genetically manipulated nematode worms so the ... part of a study that shows sexual orientation is wired ... act and think like boys, says Jamie White, a postdoctoral ... attraction] behavior is part of the nervous system. , The ...
... have identified a new molecular target that one day ... to adipocytes (fat cells) in the body and prevent ... in the Oct. 18 online edition and the November ... the findings about a specific cell receptor, known as ...
... The catastrophic fires that are sweeping Southern California are consistent ... experts say, and they may be just a prelude to ... grows heavier than usual and then ignites during prolonged drought ... happen, both in short-term fire forecasts for this year and ...
Other Biology News:Scientists alter sexual orientation in worms 2Scientists alter sexual orientation in worms 3Scientists alter sexual orientation in worms 4'Knocking out' cell receptor may help block fat deposits in tissues, prevent weight gain 2Massive California fires consistent with climate change 2
... have been developed for affinity capture ... variety of ProteinChip chemical surfaces allow ... their unique biochemical properties. Each chip ... sample comparison, and the chips are ...
... kit, 100 preps Storage: The kit is stable ... storage, keep all contents of the kit cold. ... kit utilizes a silica-gel based membrane which selectively ... the presence of specialized binding buffers. Nucleotides, oligos ...
The Sony UPD895 printer is used to print data captured with the Gel Doc XR and ChemiDoc XRS gel documentation systems as well as the VersaDoc imaging systems....
... FLISP Assay with SR-101 Labeled Substrates ... • Accurately measure serine protease activation ... • B-Bridge's FLISP Kits utilize cell-permeable, ... (FLISPs) to measure chymotrypsin-like activity in ...
Biology Products: